"
Team:Potsdam Bioware/slider
From 2012.igem.org
(Difference between revisions)
| Line 50: | Line 50: | ||
#image-1 .slider-nav { | #image-1 .slider-nav { | ||
| - | right: | + | right: 120px; |
} | } | ||
#image-2 .slider-nav { | #image-2 .slider-nav { | ||
| - | right: | + | right: 100px; |
} | } | ||
#image-3 .slider-nav { | #image-3 .slider-nav { | ||
| - | right: | + | right: 80px; |
} | } | ||
#image-4 .slider-nav { | #image-4 .slider-nav { | ||
| - | right: | + | right: 60px; |
} | } | ||
#image-5 .slider-nav { | #image-5 .slider-nav { | ||
| + | right: 40px; | ||
| + | } | ||
| + | #image-6 .slider-nav { | ||
right: 20px; | right: 20px; | ||
} | } | ||
Revision as of 09:14, 26 September 2012
To produce highly affine antibodies, a CHO (Chinese Hamster Ovary) cell line is transfected with a low affine antibody construct. The plasmid pcDNA5/FRT is used to allow the easy integration of the gene of interest into the CHO cell genome via FLP-In sites. This integration is catalyzed by the FLP-recombinase in the pOG44 plasmid.
